Schroders Capital

Portfolio Companies 2026 for Schroders Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Schroders Capital accounts for 13 tracked companies with verified cap-table data, 13 of which disclose round sizes totalling $3.9B. The median disclosed raise is $150M, and the largest is Suno at $775M, ahead of Multi Investment Holding SA ($616M) and Multiverse ($570M).

The names that recur most often on these portfolio cap tables are Schroders Capital (13 companies), Bond Capital (2 companies), Lightspeed Venture Partners (2 companies), Panacea Venture (2 companies), CTI Life Sciences (2 companies), 3B Future Health Fund (2 companies). By latest disclosed round, the market skews Growth (3), Series B (3), Series D (2), Series C (2).

Best funded Schroders Capital companies

  1. Suno — $775M (latest: Series D)
  2. Multi Investment Holding SA — $616M (latest: Growth)
  3. Multiverse — $570M (latest: Growth)
  4. Cera — $557M
  5. Indaqua — $393M (latest: Growth)
  6. Artios Pharma — $186M (latest: Series C)
  7. Azafaros — $150M (latest: Series B)
  8. Kinaset Therapeutics — $150M (latest: Series B)
  9. Draig Therapeutics — $140M (latest: Series A)
  10. Neurona Therapeutics — $126M (latest: Series B)
  11. Agrostar — $120M (latest: Series D)
  12. Memo Therapeutics — $69M (latest: Series C)
  13. Domain Therapeutics — $53M (latest: Series A)

Schroders Capital Management (Switzerland) AG — related firms and companies (56)

Schroders Capital Management (Switzerland) AG profile · All research reports